To test this hypothesis, we measured β-catenin activity in CK1ε-deficient U87MG cells, because β-catenin is one of the major signaling pathways regulated by CK1 genes in cancer cells19 and is important for gliomagenesis20,21. Here, CSNK1A1 is linked to cancer.